WELCOME
ARE YOU READY FOR YOUR NEXT INVESTMENT?
TECHNOLOGY INVESTMENT - IA
Explore our technology investment opportunity with a 3.7% annual return. Backed by market analysis and industry trends, this investment is ideal for those seeking steady and reliable growth in the tech sector.
OBJECTIVE OF THE FUND
The Fund invests in short-term loans granted via a finance company. The strategy is net long-biased with a short-term investment horizon, focused on technology investments for artificial intelligence research. Investments are selected based on fundamental technical analysis.
NEW UPCOMING
MEDICAL TECHNOLOGY INVESTMENT
Invest in cutting-edge medical technology with a 4.1% annual return. This opportunity supports advancements in healthcare, offering both impactful innovation and financial growth.
The Fund is a crowd-lending fund with a primary focus on short-term loans granted to technology companies involved in artificial intelligence research. The main objective is to achieve consis- tent capital appreciation with low volatility and minimal correlation to equity, fixed income, and alternative asset indices.
Investments are made in short-term, collaterali- zed loans granted to technology innovators, originating via the finance company. All transac- tions are executed on a discount basis.
In addition to the interest rate charged to borrowers, a Loan-to-Value (LTV) ratio is always applied, ensuring an additional margin of collate- ral. These ratios are monitored and adjusted throughout the loan period, with repayments directed to a specific collection account of the Fund.
Investment Objective
Investing in the Fund involves certain risk factors, including currency fluctuations, liquidity risks, and price volatility in financial markets. The Fund invests in short-term loans via a finance company, which may also introduce additional risk conside- rations. Furthermore, factors such as government influence on the private sector, political and economic instability, leverage, and other risks may adversely affect the Fund’s activities and invest- ments, resulting in increased share price volatility.
Risk Considerations
3,7 ANNUAL RETURN
Investing in the Fund involves certain risk factors, including currency fluctuations, liquidity risks, and price volatility in financial markets. The Fund invests in short-term loans via a finance company, which may also introduce additional risk conside- rations. Furthermore, factors such as government influence on the private sector, political and economic instability, leverage, and other risks may adversely affect the Fund’s activities and invest- ments, resulting in increased share price volatility.
Risk Considerations
CONTACT NOW!
Get more information about this specific
4,1 ANNUAL RETURN
04
Monitoring and Updates: Stay informed with regular updates and performance reports on your investment. Our advisors are available to adjust strategies as needed to maximize returns.
05
Annual Returns: Enjoy a 4.1% annual return, with options to reinvest profits or withdraw earnings based on your preferences.
Procedure
Initial Consultation: Meet with our investment advisors to discuss your goals and gain an in-depth understanding of the medical technology sector. We’ll provide detailed insights into the current market trends and potential returns.
01
Risk Assessment and Strategy: Our team conducts a thorough analysis of the investment’s risk profile and tailors a strategy that aligns with your financial objectives.
02
Investment Allocation: Funds are allocated into promising medical technology projects, focusing on innovation-driven companies and research advancements.
03
CONTACT NOW!
Get more information about this specific